Although Ki-67 expression is widely used as a tumour proliferative index and has been associated with colon cancer treatment response and prognosis (Salminen et al, 2005; Fluge et al, 2009), its clinical utility in predicting disease outcomes remains a topic of investigation. This evidence concerns the gene MKI67 and neoplasm.